Novo Nordisk A/S Class B
No trades
No trades
Price target
313.960.000.00%
The 27 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 33 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of NOVO_B is 255.95 DKK — it has decreased by −0.27% in the past 24 hours. Watch Novo Nordisk A/S Class B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange Novo Nordisk A/S Class B stocks are traded under the ticker NOVO_B.
NOVO_B stock has risen by 3.10% compared to the previous week, the month change is a −7.65% fall, over the last year Novo Nordisk A/S Class B has showed a −30.33% decrease.
We've gathered analysts' opinions on Novo Nordisk A/S Class B future price: according to them, NOVO_B price has a max estimate of 457.00 DKK and a min estimate of 200.00 DKK. Watch NOVO_B chart and read a more detailed Novo Nordisk A/S Class B stock forecast: see what analysts think of Novo Nordisk A/S Class B and suggest that you do with its stocks.
NOVO_B reached its all-time high on Jun 26, 2024 with the price of 1,033.20 DKK, and its all-time low was 0.85 DKK and was reached on Mar 28, 1988. View more price dynamics on NOVO_B chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NOVO_B stock is 2.26% volatile and has beta coefficient of 1.96. Track Novo Nordisk A/S Class B stock price on the chart and check out the list of the most volatile stocks — is Novo Nordisk A/S Class B there?
Today Novo Nordisk A/S Class B has the market capitalization of 1.13 T, it has decreased by −3.02% over the last week.
Yes, you can track Novo Nordisk A/S Class B financials in yearly and quarterly reports right on TradingView.
Novo Nordisk A/S Class B is going to release the next earnings report on Nov 4, 2026. Keep track of upcoming events with our Earnings Calendar.
NOVO_B earnings for the last quarter are 6.18 DKK per share, whereas the estimation was 5.03 DKK resulting in a 22.86% surprise. The estimated earnings for the next quarter are 4.69 DKK per share. See more details about Novo Nordisk A/S Class B earnings.
Novo Nordisk A/S Class B revenue for the last quarter amounts to 78.49 B DKK, despite the estimated figure of 71.35 B DKK. In the next quarter, revenue is expected to reach 72.93 B DKK.
NOVO_B net income for the last quarter is 20.99 B DKK, while the quarter before that showed 48.56 B DKK of net income which accounts for 0.00% change. Track more Novo Nordisk A/S Class B financial stats to get the full picture.
Yes, NOVO_B dividends are paid semi-annually. The last dividend per share was 3.75 DKK. As of today, Dividend Yield (TTM)% is 4.56%. Tracking Novo Nordisk A/S Class B dividends might help you take more informed decisions.
Novo Nordisk A/S Class B dividend yield was 3.60% in 2025, and payout ratio reached 50.75%. The year before the numbers were 1.83% and 50.28% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 15, 2026, the company has 68.79 K employees. See our rating of the largest employees — is Novo Nordisk A/S Class B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Novo Nordisk A/S Class B EBITDA is 169.89 B DKK, and current EBITDA margin is 48.43%. See more stats in Novo Nordisk A/S Class B financial statements.
Like other stocks, NOVO_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Novo Nordisk A/S Class B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Novo Nordisk A/S Class B technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Novo Nordisk A/S Class B stock shows the sell signal. See more of Novo Nordisk A/S Class B technicals for a more comprehensive analysis.